Ola Borjesson
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden.
Journal: Scandinavian journal of rheumatology
Published: May 22, 2026
Incidence and prevalence of granulomatosis with polyangiitis in Sweden, 2006-2019, a register-based study.
Journal: Seminars in arthritis and rheumatism
Published: January 21, 2025
Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis.
Journal: Scandinavian journal of rheumatology
Published: September 20, 2022
Venous thromboembolism in anti-neutrophil cytoplasmic antibody-associated vasculitis: an underlying prothrombotic condition?
Journal: Rheumatology advances in practice
Published: June 26, 2020
Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis.
Journal: Scandinavian journal of rheumatology
Published: March 07, 2019
Circulatory Collapse due to Hyperinflation in a Patient with Tracheobronchomalacia: A Case Report and Brief Review.
Journal: Case reports in critical care
Published: December 13, 2018
Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
Journal: Scandinavian journal of rheumatology
Published: March 08, 2016
Macrophage migration inhibitory factor (MIF) and thyroid hormone alterations in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Journal: Molecular medicine (Cambridge, Mass.)
Published: December 27, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026